http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#Head
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#assertion
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#provenance
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#pubinfo
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#assertion
http://purl.obolibrary.org/obo/DOID_10808
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_10808
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00585
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#association
http://www.w3.org/2000/01/rdf-schema#label
nizatidineoral solution is indicated for up to 8 weeks for the treatment of active duodenal ulcer in most patients the ulcer will heal within 4 weeks nizatidineoral solution is indicated for maintenance therapy for duodenal ulcer patients at a reduced dosage of 15 mg h s after healing of an active duodenal ulcer the consequences of continuous therapy with nizatidine for longer than 1 year are not known nizatidine oral solution is indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis including erosive and ulcerative esophagitis and associated heartburn due to gerd nizatidine oral solution is indicated for up to 8 weeks for the treatment of active benign gastric ulcer before initiating therapy care should be taken to exclude the possibility of malignant gastric ulceration in pediatric patients nizatidine oral solution is indicated for ages 12 years and older nizatidine oral solution is indicated for up to 8 weeks for the treatment of endoscopically diagnosed esophagitis including erosive and ulcerative esophagitis and associated heartburn due to gerd
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00585
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#provenance
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#pubinfo
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#sig
http://purl.org/nanopub/x/hasSignature
dtMzWY/N4q/7JCekBf7UTJ2q7jsB0Q2po52lPjjHxPF4bw0dkNywr+1DYoWDArYBr/1cHTRhjo1Me9Mb+UlY5Ya88FKgznLhSMfzAXfyo3I5D3PvC6M8v2CylnBNKNWF4DcZ0N+hSCrZ0IDYzrLetUXmgnPHJWIhnQANA7nHKXs=
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
http://purl.org/dc/terms/created
2021-07-03T12:07:24.170+02:00
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs